JP2013503831A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013503831A5 JP2013503831A5 JP2012527293A JP2012527293A JP2013503831A5 JP 2013503831 A5 JP2013503831 A5 JP 2013503831A5 JP 2012527293 A JP2012527293 A JP 2012527293A JP 2012527293 A JP2012527293 A JP 2012527293A JP 2013503831 A5 JP2013503831 A5 JP 2013503831A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- magnetic field
- phase
- magnetizable particles
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 2
- 238000001125 extrusion Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 229920001169 thermoplastic Polymers 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims 27
- 238000009472 formulation Methods 0.000 claims 9
- 239000002775 capsule Substances 0.000 claims 8
- 239000007787 solid Substances 0.000 claims 5
- 238000001514 detection method Methods 0.000 claims 3
- 238000011156 evaluation Methods 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 230000005415 magnetization Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000006186 oral dosage form Substances 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 238000007711 solidification Methods 0.000 claims 2
- 230000008023 solidification Effects 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 229940088623 biologically active substance Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000003618 dip coating Methods 0.000 claims 1
- 239000008393 encapsulating agent Substances 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 229920006254 polymer film Polymers 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000007704 transition Effects 0.000 claims 1
- 239000000463 material Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23961309P | 2009-09-03 | 2009-09-03 | |
| US61/239,613 | 2009-09-03 | ||
| DE102009029170.9 | 2009-09-03 | ||
| DE102009029170 | 2009-09-03 | ||
| PCT/EP2010/062641 WO2011026808A1 (en) | 2009-09-03 | 2010-08-30 | Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013503831A JP2013503831A (ja) | 2013-02-04 |
| JP2013503831A5 true JP2013503831A5 (enExample) | 2013-10-03 |
| JP5868319B2 JP5868319B2 (ja) | 2016-02-24 |
Family
ID=42984007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012527293A Expired - Fee Related JP5868319B2 (ja) | 2009-09-03 | 2010-08-30 | １つ以上の生物学的活性物質、調合補助物質および磁化可能粒子を包含する経口剤形 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9050256B2 (enExample) |
| EP (1) | EP2473095B1 (enExample) |
| JP (1) | JP5868319B2 (enExample) |
| KR (1) | KR101731130B1 (enExample) |
| CN (1) | CN102573612B (enExample) |
| BR (1) | BR112012004967B8 (enExample) |
| CA (1) | CA2772708C (enExample) |
| ES (1) | ES2528494T3 (enExample) |
| IL (1) | IL217897A (enExample) |
| MX (1) | MX2012002677A (enExample) |
| PL (1) | PL2473095T3 (enExample) |
| SI (1) | SI2473095T1 (enExample) |
| WO (1) | WO2011026808A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2755623A1 (en) * | 2011-09-14 | 2014-07-23 | University of Florida | Smarttm solid oral dosage forms |
| DE102011089334A1 (de) | 2011-12-21 | 2013-06-27 | Evonik Röhm Gmbh | Detektionssystem zur Erfassung magnetischer Objekte im menschlichen Organismus |
| US11667906B2 (en) * | 2014-11-24 | 2023-06-06 | Corning Incorporated | Magnetic microcarriers |
| US11024449B2 (en) * | 2017-06-06 | 2021-06-01 | Apple Inc. | Multipole elastomeric magnet with magnetic-field shunt |
| BR112020011294A2 (pt) | 2017-12-04 | 2020-11-17 | Evonik Operations Gmbh | corpo com várias fases e o emprego do mesmo |
| US10679018B1 (en) | 2019-02-05 | 2020-06-09 | International Business Machines Corporation | Magnetic tracking for medicine management |
| US10824822B2 (en) * | 2019-02-05 | 2020-11-03 | International Business Machines Corporation | Magnetic tracking for medicine management |
| JP7502741B2 (ja) * | 2019-09-26 | 2024-06-19 | スピンセンシングファクトリー株式会社 | 磁気マーカーおよび磁気マーカー検出システム |
| CA3193833A1 (en) | 2020-10-09 | 2022-04-14 | Juliette HORDEAUX | Compositions and methods for treatment of fabry disease |
| CN112360304A (zh) * | 2020-11-06 | 2021-02-12 | 炫丽建材江苏有限公司 | 一种适用于22度免拉手门板的自愈合封边工艺 |
| CN116887866A (zh) | 2020-12-03 | 2023-10-13 | 巴特尔纪念研究院 | 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法 |
| JP2024516108A (ja) | 2021-04-07 | 2024-04-12 | バテル・メモリアル・インスティテュート | 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術 |
| CN119317645A (zh) | 2022-04-06 | 2025-01-14 | 宾夕法尼亚州大学信托人 | 用于治疗her2阳性转移性乳腺癌及其他癌症的组合物和方法 |
| EP4504258A1 (en) | 2022-04-06 | 2025-02-12 | The Trustees of the University of Pennsylvania | Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025122954A1 (en) | 2023-12-08 | 2025-06-12 | Battelle Memorial Institute | Use of dna origami nanostructures for molecular information based data storage systems |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3723310A1 (de) | 1987-07-15 | 1989-01-26 | John Urquhart | Pharmazeutisches praeparat und verfahren zu seiner herstellung |
| DE3740187A1 (de) | 1987-11-27 | 1989-06-08 | Urquhart John | Verfahren und vorrichtung zum ueberwachen und/oder kontrollieren und/oder registrieren und/oder anzeigen der einnahme von pharmazeutischen praeparaten |
| DE3940260A1 (de) | 1989-03-04 | 1990-09-13 | Werner Weitschies | Verfahren zur bestimmung des aufenthaltsortes und der bewegung von objekten durch ihre markierung als magnetisches moment |
| CN1056049C (zh) | 1994-02-02 | 2000-09-06 | 湖南省商业科技研究所 | 一种磁疗食品的制备方法 |
| JP2000516504A (ja) | 1996-08-16 | 2000-12-12 | ロシュ ダイアグノスティックス ゲーエムベーハー | 薬剤の規則的摂取の監視システム |
| JP2004331750A (ja) * | 2003-05-02 | 2004-11-25 | Canon Inc | ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途 |
| EP1557151A1 (en) * | 2004-01-22 | 2005-07-27 | F. Hoffmann-La Roche Ag | Solid dosage form |
| CN100355454C (zh) * | 2005-10-25 | 2007-12-19 | 南京工业大学 | 磁热疗用纳米磁粉－抗人肝癌单抗HAb18靶向药物 |
| EP1880716A1 (en) | 2006-07-19 | 2008-01-23 | Sandoz AG | Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| DE102008033662A1 (de) | 2008-07-11 | 2010-01-14 | Technische Universität Ilmenau | Pharmakologische Darreichungsform und Vorrichtung und Verfahren zur kontinuierlichen Lokalisierung und Verfolgung des Auflösevorganges dieser |
-
2010
- 2010-08-30 MX MX2012002677A patent/MX2012002677A/es active IP Right Grant
- 2010-08-30 ES ES10747220.1T patent/ES2528494T3/es active Active
- 2010-08-30 BR BR112012004967A patent/BR112012004967B8/pt not_active IP Right Cessation
- 2010-08-30 CA CA2772708A patent/CA2772708C/en active Active
- 2010-08-30 EP EP10747220.1A patent/EP2473095B1/en active Active
- 2010-08-30 KR KR1020127005600A patent/KR101731130B1/ko not_active Expired - Fee Related
- 2010-08-30 SI SI201030850T patent/SI2473095T1/sl unknown
- 2010-08-30 JP JP2012527293A patent/JP5868319B2/ja not_active Expired - Fee Related
- 2010-08-30 WO PCT/EP2010/062641 patent/WO2011026808A1/en not_active Ceased
- 2010-08-30 US US13/390,353 patent/US9050256B2/en active Active
- 2010-08-30 CN CN201080039021.4A patent/CN102573612B/zh not_active Expired - Fee Related
- 2010-08-30 PL PL10747220T patent/PL2473095T3/pl unknown
-
2012
- 2012-02-02 IL IL217897A patent/IL217897A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013503831A5 (enExample) | ||
| Behrens et al. | Magnetic nanocomposites | |
| Lee et al. | Heterostructured magnetic nanotubes | |
| Kafrouni et al. | Recent progress on magnetic nanoparticles for magnetic hyperthermia | |
| Pondman et al. | Magnetic drug delivery with FePd nanowires | |
| Tseng et al. | Liposomes incorporated with cholesterol for drug release triggered by magnetic field | |
| Li et al. | Current investigations into magnetic nanoparticles for biomedical applications | |
| Di Corato et al. | Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs | |
| CN102573612B (zh) | 包含至少一种生物活性剂、制剂辅助物质和可磁化粒子的口服剂型 | |
| Wang et al. | Integrity of 111In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse | |
| Cerdan et al. | Magnetic self-healing composites: synthesis and applications | |
| Dutta et al. | Development of a novel probe sonication assisted enhanced loading of 5-FU in SPION encapsulated pectin nanocarriers for magnetic targeted drug delivery system | |
| US20170143830A1 (en) | Cellular Micromotors and Uses Thereof | |
| JP2006523492A5 (enExample) | ||
| Jabalera et al. | Magnetoliposomes of mixed biomimetic and inorganic magnetic nanoparticles as enhanced hyperthermia agents | |
| Cao et al. | Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging | |
| Zhang et al. | Multi-stimuli-responsive magnetic assemblies as tunable releasing carriers | |
| Allam et al. | Stability and magnetically induced heating behavior of lipid-coated Fe3O4 nanoparticles | |
| Avilés et al. | In vitro study of magnetic particle seeding for implant assisted-magnetic drug targeting | |
| Rittikulsittichai et al. | Preparation, characterization, and utilization of multi-functional magnetic-fluorescent composites for bio-imaging and magnetic hyperthermia therapy | |
| Gineste et al. | Hybrid polymeric micelles stabilized by gallium ions: Structural investigation | |
| JP2016225551A5 (enExample) | ||
| Dunn et al. | Recent developments in the design of nanomaterials for photothermal and magnetic hyperthermia induced controllable drug delivery | |
| CN104465000B (zh) | 一种包含氧化锌包覆四氧化三铁磁性介孔材料的制备方法 | |
| Gao et al. | Acoustophoretic Motion of Erythrocyte‐mimicking Hemoglobin Micromotors |